Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases
NCT ID: NCT02319252
Last Updated: 2018-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2015-01-31
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary outcome will be differences in nutrition intake between the groups. Secondary outcomes will be: the amount of unplanned tube discontinuations; handgrip and patients' quality of life, nausea \& vomiting.
The study will include 40 patients at Aarhus University Hospital, Denmark.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease
NCT02140294
Intensive Enteral Nutrition and Acute Alcoholic Hepatitis
NCT01801332
Vector Analysis of Body Composition in Hospitalized Cirrhotic Patients
NCT02017301
Indirect Calorimeter Based Study in Patients With Liver Cirrhosis
NCT03871894
Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis)
NCT04544020
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastric tube
A gastric tube is used
Gastric tube (Nutricia Flocare® Pur Tube Enlock)
Nutricia Flocare® Pur Tube Enlock, Ch. 12
Jejunal tube
A jejunal tube is used
Jejunal tube (Nutricia Flocare® Bengmark®)
Nutricia Flocare® Bengmark®, Ch. 10
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gastric tube (Nutricia Flocare® Pur Tube Enlock)
Nutricia Flocare® Pur Tube Enlock, Ch. 12
Jejunal tube (Nutricia Flocare® Bengmark®)
Nutricia Flocare® Bengmark®, Ch. 10
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* nutrition intake less than 75% of needed intake
* Signed informed consent form
Exclusion Criteria
* Anatomic barriers to have a tube placed
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Palle Bager, PhD
Role: PRINCIPAL_INVESTIGATOR
Aarhus University Hospital, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, Central Region, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tubes in liver diseases
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.